CheckMyRecalls

Par Health USA, LLC recalls Buprenorphine Hydrochloride

Published
7 Oct 2026
Units affected
154210 bottles
Agency
FDA
Country
United States

The hazard

Crystallization

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Buprenorphine Hydrochloride, Injection 0.3 mg/mL, Rx Only, 5 x 1 mL Single Dose Vials, Manufactured for: Endo USA, Malvern, PA, NDC 42023-179-05

Brand / company
Par Health USA, LLC
Codes / lots
Lot#:83912, Exp Date 10/2026 Lot#:84234, Exp Date 11/2026 Lot#:84990, Exp Date 11/2026 Lot#:85003, Exp Date 12/2026 Lot#:86443, Exp Date 01/2027 Lot#:89909, Exp Date 05/2027
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.